Table 2.
Antibiotic treatment, type, and duration in 44 cured patients with prosthetic valve endocarditis (PVE) caused by Propionibacterium spp.a
| Type of antibiotic | Total (n = 44) | Surgically treated (n = 28) | Medically treated (n = 16) | |||
|---|---|---|---|---|---|---|
| Treatment duration, days, median (range) | Patients, no. | Treatment duration, days, median (range) | Patients, no. | Treatment duration, days, median (range) | Patients, no. | |
| Total antibiotic treatment | 42 (18–117) | 44 | 41 (18–80) | 28 | 42 (28–117) | 16 |
| Beta-lactam | 38 (9–71) | 43 | 33 (9–71) | 27 | 41 (19–47) | 16 |
| - PcG | 33 (16–61) | 40 | 33 (16–61) | 26 | 38 (24–43) | 14 |
| - Cefuroxime/ceftriaxone/cefotaxime | 7 (2–40) | 14 | 8 (2–40) | 9 | 13 (2–29) | 5 |
| Vancomycin | 9 (2–40) | 26 | 9 (2–37) | 17 | 10 (5–42) | 9 |
| Aminoglycoside | 14 (2–41) | 37 | 10 (2–41) | 24 | 14 (2–39) | 13 |
| Clindamycin | 15 (3–80) | 9 | 14 (3–42) | 7 | 48 (15–80) | 2 |
| Rifampicin | 19 (7–43) | 7 | 10 (7–43) | 3 | 24 (11–32) | 4 |
aExcluded are one patient who died after 18 days of treatment, one patient with relapse 12 months post-treatment, and two episodes for one patient with two relapses 10 and 15 months post-treatment. Three patients had no data available